IR vs MR [PK / PD]

posted by jag009  – NJ, 2013-11-14 00:03 (4253 d 15:40 ago) – Posting: # 11879
Views: 5,496

Hi,

Are you referring to one IR table to one ER tablet? If so, no because that's not really the intent of a MR product. MR product has a slower rate of drug release -> 1) aim to lower the incidence of adverse events, 2) to provide a once daily blood level coverage (24 hrs).

Now I have seen submission in which BE was demonstrated between 1 MR tablet vs IR tablets given several times daily. Yes meeting the 90% CIs for AUC and Cmax. It was a 505(b)2 filing.

John

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,680 registered users;
89 visitors (0 registered, 89 guests [including 25 identified bots]).
Forum time: 16:44 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5